Journey Medical Corporation is a commercial-stage pharmaceutical company focused on selling and marketing FDA-approved prescription drugs for dermatological conditions. Its portfolio includes eight products targeting rosacea, acne, primary axillary hyperhidrosis, and fungal skin infections, marketed under brands such as Emrosi, Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Exelderm, and Luxamend. The company acquires product rights through licensing or ownership, funds R&D, and commercializes via its field sales organization. It is a controlled subsidiary of Fortress Biotech, Inc.
Q2 FY2026 — expected 2026-09-16
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-26 | 2025-12-31 | 0001104659-26-034629 | EDGAR | 69K words |
| 2025-03-27 | 2024-12-31 | 0001410578-25-000490 | EDGAR | 69K words |
| 2024-03-29 | 2023-12-31 | 0001410578-24-000347 | EDGAR | 68K words |
| 2023-03-31 | 2022-12-31 | 0001410578-23-000485 | EDGAR | — |
| 2022-03-28 | 2021-12-31 | 0001410578-22-000558 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-12 | 2026-06-30 | 0001104659-26-094948 | EDGAR | 20K words |
| 2025-11-12 | 2025-09-30 | 0001104659-25-110457 | EDGAR | 22K words |
| 2025-08-12 | 2025-06-30 | 0001410578-25-001703 | EDGAR | 20K words |
| 2025-05-15 | 2025-03-31 | 0001410578-25-001296 | EDGAR | 18K words |
| 2024-11-12 | 2024-09-30 | 0001410578-24-001877 | EDGAR | 21K words |
| 2024-08-13 | 2024-06-30 | 0001410578-24-001326 | EDGAR | 19K words |
| 2024-05-14 | 2024-03-31 | 0001410578-24-000817 | EDGAR | 15K words |
| 2023-11-13 | 2023-09-30 | 0001410578-23-002335 | EDGAR | 22K words |
| 2023-08-10 | 2023-06-30 | 0001410578-23-001702 | EDGAR | 21K words |
| 2023-05-22 | 2023-03-31 | 0001410578-23-001327 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001410578-22-003162 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001410578-22-002183 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-12 | 0001104659-26-094862 | EDGAR | 4K words |
| 2026-03-25 | 0001104659-26-034506 | EDGAR | 4K words |
| 2025-11-12 | 0001104659-25-110344 | EDGAR | 4K words |
| 2025-09-26 | 0001104659-25-093891 | EDGAR | 1K words |
| 2025-08-28 | 0001104659-25-084879 | EDGAR | 23K words |
| 2025-08-12 | 0001104659-25-076825 | EDGAR | 4K words |
| 2025-07-14 | 0001104659-25-067767 | EDGAR | 2K words |
| 2025-06-26 | 0001104659-25-063032 | EDGAR | 5K words |
| 2025-06-24 | 0001104659-25-061956 | EDGAR | 1K words |
| 2025-05-14 | 0001104659-25-048502 | EDGAR | 4K words |
76 total filings indexed. 49 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001867066 |
| Ticker | DERM |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Headquarters | Scottsdale, AZ |
| Website | https://www.jmcderm.com |
| Listed | 2021-11-12 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/DERM (~200 tokens, structured JSON with cryptographic provenance)